File(s) under permanent embargo

P2.03-044 OSCILLATE - Phase 2 Trial of Alternating Osimertinib with Gefitinib in Patients with EGFR-T790M Mutation Positive Advanced NSCLC

journal contribution

posted on 2023-03-17, 05:07 authored by B Solomon, P Kok, A Livingstone, S Yip, C Brown, S Dawson, S Wong, N Pavlakis, M Stockler

P2.03-044 OSCILLATE - Phase 2 Trial of Alternating Osimertinib with Gefitinib in Patients with EGFR-T790M Mutation Positive Advanced NSCLC

History

Journal

Journal of Thoracic Oncology

Volume

12

Pagination

S2144-S2144

Publisher DOI

https://doi.org/10.1016/j.jtho.2017.09.1295

ISSN

1556-0864

Language

en

Issue

11

Publisher

Elsevier BV

Usage metrics

Read the peer-reviewed publication

P2.03-044 OSCILLATE - Phase 2 Trial of Alternating Osimertinib with Gefitinib in Patients with EGFR-T790M Mutation Positive Advanced NSCLC

Research Publications

Categories

Keywords

Uncategorised value

Licence

All Rights Reserved

Exports